Viewing Study NCT07016412


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2025-12-26 @ 10:17 PM
Study NCT ID: NCT07016412
Status: RECRUITING
Last Update Posted: 2025-10-14
First Post: 2025-06-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
Sponsor: Verona Pharma plc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module